Approvals/TGA/EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle

Approved

STANDARD

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6ca38b8a820323d3
Product Name: EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle
Artg Id: 431932
Artg Name: EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2025-03-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-PI-01507-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6ca38b8a820323d3

Type

Standard